Oxybutynin (Ditropan) Production Cost Reports

The report provides a detailed analysis essential for establishing an Oxybutynin (Ditropan) manufacturing plant. It encompasses all critical aspects necessary for Oxybutynin (Ditropan) production, including the cost of Oxybutynin (Ditropan) production, Oxybutynin (Ditropan) plant cost, Oxybutynin (Ditropan) production costs, and the overall Oxybutynin (Ditropan) manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Oxybutynin (Ditropan) production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Oxybutynin is an effective medication that helps in managing overactive bladder (OAB). It works by relaxing the muscles of the bladder while increasing its for even urination. It belongs to the type of antispasmodics or antimuscarinic drugs and mainly deals with bladder-related issues and treats urological problems. It effectively heals urinating problems, including bladder instability. It decreases bladder contractions and relaxes the smooth muscles of the bladder while blocking the release of acetylcholine, which is responsible for muscle contraction within the bladder in the body. It is available in different forms, including oral pills, capsules, oral solutions, transdermal patches, and a transdermal gel.

The oxybutynin market growth is driven by several key factors, including the rising cases of overactive bladder (OAB), mainly in the aging population. The development of better drug delivery systems, such as transdermal patches and gels, improves patient compliance and comfort, which contributes to its demand. Increased investments in healthcare infrastructure give better access to medications, and regulatory environments support the approval of new formulations. Its availability in different forms, like oral tablets and extended-release formulations, allows for customized treatment. Altogether, these factors contribute to industrial Oxybutynin procurement around the globe.

Raw Material for Oxybutynin Production

According to the Oxybutynin manufacturing plant project report, the key raw materials used in the production of Oxybutynin include Methyl ester of α-Phenyl-α-Cyclohexaneglycolic Acid-(1-Acetoxy-4-Diethylamino-2-Butene)-Sodium Methoxide.

Manufacturing Process of Oxybutynin

The extensive Oxybutynin production cost report consists of the following major industrial manufacturing process:

1. Production From Methyl ester of α-Phenyl-α-Cyclohexaneglycolic Acid, 1-Acetoxy-4-Diethylamino-2-Butene, and Sodium Methoxide: The manufacturing process of Oxybutynin involves transesterification reaction. In this process, methyl ester of α-phenyl-α-cyclohexaneglycolic acid reacts with 1-acetoxy-4-diethylamino-2-butene in the presence of sodium methoxide as a catalyst, forming Oxybutynin as the final product.

Oxybutynin is a white crystalline solid with a molecular formula of C22H31NO3 and a molecular weight of 357.5 g/mol. It is freely soluble in water, ethyl alcohol, DMSO, and dimethyl formamide. Its melting point is in the range of 129 to 130°.  Its dissociation constant (pKa) value is 8.04, with a log P value of about 2.9 at pH 6, making it moderately lipophilic in nature. It remains stable under normal storage conditions. It is an FDA-approved chemical medication and is majorly considered an anticholinergic and antispasmodic drug in the pharmaceutical and healthcare sectors.